Novel histone deacetylase inhibitor. Produces > 100-fold increase in histone acetylation and displays relatively low toxicity.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library.
Su et al.
Cancer Res., 2000;60:3137